McGuireWoods partner and host Geoff Cockrell invites Jeremy Johnson, senior managing director at Bourne Partners investment bank, for a discussion about business and investment prospects in three healthcare sectors: pharma services, provider services and payor services.
The pharma services sector faces challenges from reduced biopharma funding while the provider services sector sees improving conditions…
InTandem Capital Partners has announced it has completed an investment in Clinilabs.
Clinilabs, founded in 2000 and based in Eatontown, New Jersey, is a contract research organization focused on central nervous system drug, device and technology development.
InTandem, founded in 2011 and based in New York, focuses on acquiring middle market healthcare services…
Eir Partners Capital has announced a growth investment in Porter.
Porter, founded in 2021 and based in Baltimore, Maryland, is a healthcare information technology and services platform for care and coverage coordination.
Eir, founded in 2015 and based in Miami, is a middle market private equity firm focused on healthcare technology and tech-enabled…
Pamlico Capital has announced the closing of its sixth fund.
The fund, Pamlico Capital VI, closed at the fund’s hard cap of $1.75 billion. It was oversubscribed, exceeding its initial $1.5 billion target.
Pamlico, founded in 1988 and based in Charlotte, North Carolina, is a private equity firm that invests in middle-market companies in…
Sycamore Partners will acquire Walgreens Boots Alliance (WBA), according to a news release.
WBA (NASDAQ: WBA), based in Deerfield, Illinois, is an integrated healthcare, pharmacy and retail company.
Sycamore, founded in 2011 and based in New York, is a private equity firm specializing in retail and consumer investments.
Sycamore is acquiring Walgreens and…
As a $4.6 trillion industry in the United States, “pretty much everything is connected or interconnected to healthcare,” says Gyasi Chisley, head of corporate healthcare at PNC Bank. “So, that positions us for another interesting and pivotal year in 2025.”
In a conversation with McGuireWoods partner and host Geoff Cockrell, Gyasi highlights…
An affiliate of Peak Rock Capital will acquire BrightStar Group Holdings (BrightStar Care), according to a news release.
BrightStar Care, founded in 2002 and based in Gurnee, Illinois, is franchisor of home care services with more than 400 agencies nationwide.
Peak Rock, founded in 2012 and based in Austin, Texas, is middle…
On Feb. 18, 2025, the U.S. Court of Appeals for the First Circuit adopted the “but for” causality standard for violations of the federal Anti-Kickback Statute (AKS) that give rise to violations of the federal False Claims Act (FCA). In United States v. Regeneron, the First Circuit held that for a violation of the AKS to constitute a false claim subject to the FCA, the government must demonstrate that the illicit kickback was the “but for” cause of a submitted claim.
This holding ended an intra-circuit split between two district court opinions including the lower court’s ruling in this case and aligns the First Circuit with the Sixth and Eighth circuits’ interpretations. The holding leaves the Third Circuit as the only circuit allowing the government to rely on a “causal link” standard between an AKS violation and the submission of a false claim subject to the FCA.
McGuireWoods’ Ponzi Litigation team launched its Ponzi Perspectives blog in early 2021. Throughout the past four years, we’ve tracked and posted case alerts on Ponzi-related complaints filed in federal and state courts throughout the country, analyzed key decisions that have the potential to influence controlling law, and posted practical considerations for financial institutions to consider when facing claims from defrauded investors or court appointed receivers and trustees. This 2024 year-end round up summarizes the cases and opinions analyzed throughout the year and highlights anticipated trends for 2025.
After the Financial Crimes Enforcement Network (FinCEN) stated that it would hold off on taking enforcement actions against Reporting Companies for failure to comply with the March 21, 2025, deadline under the Corporate Transparency Act (CTA), the U.S. Department of the Treasury announced its own intention to limit CTA enforcement to foreign companies.
